Skip to content
Screener

Jade Biosciences JBIO Market capitalization

Market capitalization at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$126.07B+9.0%
Climb Global Solutions, Inc. logo
Climb Global Solutions, Inc.CLMB
$365.14M-28.3%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$2.74B+72.3%
Vera Therapeutics logo
Vera TherapeuticsVERA
$2.87B+87.5%
Vor Biopharma logo
Vor BiopharmaVOR
$871.44M+873%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.59B+180%

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K—
Free cash flow-$33.7M—

Valuation

See full
Enterprise value$1.3B+3,925%

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity0×—
Current ratio14.3×-17.7×

Where this comes from

Computed from the period-end share price: $692.89M.

The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 4:27 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-212088

FAQ

What is Jade Biosciences's market capitalization?
Jade Biosciences (JBIO) reported market capitalization of $692.89M in Q1 2026.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

Ask your AI about Jade Biosciences's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude